Yong Dai

9.4k total citations
435 papers, 7.0k citations indexed

About

Yong Dai is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Yong Dai has authored 435 papers receiving a total of 7.0k indexed citations (citations by other indexed papers that have themselves been cited), including 210 papers in Molecular Biology, 93 papers in Cancer Research and 65 papers in Immunology. Recurrent topics in Yong Dai's work include MicroRNA in disease regulation (54 papers), Cancer-related molecular mechanisms research (48 papers) and RNA modifications and cancer (41 papers). Yong Dai is often cited by papers focused on MicroRNA in disease regulation (54 papers), Cancer-related molecular mechanisms research (48 papers) and RNA modifications and cancer (41 papers). Yong Dai collaborates with scholars based in China, United States and Hong Kong. Yong Dai's co-authors include Donge Tang, Weiguo Sui, Fengping Zheng, Minglin Ou, Wujian Peng, He Huang, Yuanshuai Huang, Min Tang, Lianghong Yin and Xin Ouyang and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Renewable and Sustainable Energy Reviews.

In The Last Decade

Yong Dai

415 papers receiving 6.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yong Dai China 42 3.7k 2.2k 1.3k 928 644 435 7.0k
Éric Boilard Canada 45 3.5k 1.0× 1.1k 0.5× 1.7k 1.3× 689 0.7× 727 1.1× 125 7.1k
Yang� Yang China 45 4.3k 1.2× 3.1k 1.4× 732 0.6× 389 0.4× 1.1k 1.8× 379 7.6k
Gopal C. Kundu India 50 3.6k 1.0× 1.5k 0.7× 877 0.7× 1.6k 1.7× 1.5k 2.4× 134 7.3k
Nan Shen China 50 5.1k 1.4× 3.0k 1.4× 3.5k 2.8× 1.9k 2.1× 1.0k 1.6× 257 11.0k
Mónica Gumá United States 39 2.5k 0.7× 1.2k 0.6× 3.1k 2.5× 1.5k 1.6× 1.1k 1.8× 119 7.4k
Johannes Grillari Austria 45 4.6k 1.2× 2.0k 0.9× 640 0.5× 217 0.2× 553 0.9× 215 7.3k
Shu Ye United Kingdom 52 2.9k 0.8× 3.0k 1.4× 1.0k 0.8× 402 0.4× 1.3k 2.0× 229 9.2k
Zhongmin Liu China 50 2.9k 0.8× 935 0.4× 1.7k 1.4× 284 0.3× 745 1.2× 235 7.1k
Junfeng Zhang China 47 3.2k 0.9× 1.8k 0.8× 911 0.7× 384 0.4× 737 1.1× 119 6.5k
Iris Barshack Israel 46 3.3k 0.9× 1.6k 0.7× 1.3k 1.0× 456 0.5× 1.6k 2.5× 258 8.1k

Countries citing papers authored by Yong Dai

Since Specialization
Citations

This map shows the geographic impact of Yong Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yong Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yong Dai more than expected).

Fields of papers citing papers by Yong Dai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yong Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yong Dai. The network helps show where Yong Dai may publish in the future.

Co-authorship network of co-authors of Yong Dai

This figure shows the co-authorship network connecting the top 25 collaborators of Yong Dai. A scholar is included among the top collaborators of Yong Dai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yong Dai. Yong Dai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Sun, Yong, Shanshan Shi, Yuan Li, et al.. (2025). Triclabendazole inhibits PKM2 nuclear localization and glycolysis by enhancing HDAC6-mediated deacetylation in lung cancer. Journal of Translational Medicine. 23(1). 1001–1001. 1 indexed citations
3.
Zhou, Changjian, Yinxian Song, Guiyun Yu, et al.. (2025). Nitrogen-doped biomass carbon aerogel with self-cleaning ability enhanced copper plasmonic effect for solar evaporation. Carbon. 244. 120708–120708. 3 indexed citations
4.
Lv, Wenyu, Keli Liu, Yunhua Li, et al.. (2025). Endothelial SMAD4 Deficiency Promotes Pulmonary Hypertension by Impairing Cell Adhesion and Extracellular Matrix Organization. Hypertension. 82(7). 1175–1191. 1 indexed citations
5.
Lu, Yong-Ping, Mengxian Zhang, Baozhang Guan, et al.. (2024). Mechanism of the cardioprotective effect of empagliflozin on diabetic nephropathy mice based on the basis of proteomics. Proteome Science. 22(1). 9–9. 1 indexed citations
6.
Xiong, Xiaoli, Jing Wang, Hao Zhang, et al.. (2024). MRI-based bone marrow radiomics for predicting cytogenetic abnormalities in multiple myeloma. Clinical Radiology. 79(4). e491–e499. 1 indexed citations
7.
Cheng, Pengyu, et al.. (2024). Adversarial Preference Optimization: Enhancing Your Alignment via RM-LLM Game. 3705–3716. 3 indexed citations
9.
Zheng, Fengping, Donge Tang, Shanshan Li, et al.. (2023). Spatial proteomics landscape and immune signature analysis of renal sample of lupus nephritis based on laser-captured microsection. Inflammation Research. 72(8). 1603–1620. 6 indexed citations
10.
Yan, Xiuwen, Hang Ding, Xiaoyi Chen, et al.. (2023). Long non-coding RNA BC002811 Promotes Gastric Cancer Metastasis by Regulating SOX2 Binding to the PTEN Promoter. International Journal of Biological Sciences. 19(3). 967–980. 10 indexed citations
11.
Tang, Donge, et al.. (2022). Metabolomics study reveals the alteration of fatty acid oxidation in the hearts of diabetic mice by empagliflozin. Molecular Omics. 18(7). 643–651. 8 indexed citations
12.
Hou, Xianliang, Xiaoping Hong, Minglin Ou, et al.. (2022). Analysis of Gene Expression and TCR/B Cell Receptor Profiling of Immune Cells in Primary Sjögren’s Syndrome by Single-Cell Sequencing. The Journal of Immunology. 209(2). 238–249. 32 indexed citations
13.
He, Jingquan, Yumei Chen, Wen Xue, et al.. (2021). Intestinal microbiome and metabolome analyses reveal metabolic disorders in the early stage of renal transplantation. Molecular Omics. 17(6). 985–996. 5 indexed citations
14.
Liu, Jiayi, Yu Shangguan, Donge Tang, & Yong Dai. (2021). Histone succinylation and its function on the nucleosome. Journal of Cellular and Molecular Medicine. 25(15). 7101–7109. 54 indexed citations
15.
Ou, Minglin, Min Zhao, Chunhong Li, et al.. (2021). Single-cell sequencing reveals the potential oncogenic expression atlas of human iPSC-derived cardiomyocytes. Biology Open. 10(2). 9 indexed citations
16.
Wang, Xiaobin, Hanlin Wang, Jianming Tang, et al.. (2021). Comparative Proteomic Analysis to Investigate the Pathogenesis of Oral Adenoid Cystic Carcinoma. ACS Omega. 6(29). 18623–18634. 8 indexed citations
17.
Chen, Sheng, Hui Peng, Ling Yao, et al.. (2020). Prediction of Risk Factors for the Evolution of Traumatic Subdural Effusion into Chronic Subdural Hematoma. SHILAP Revista de lepidopterología.
18.
Dai, Yong, et al.. (2020). Long Noncoding RNA (lncRNA) MT1JP Suppresses Hepatocellular Carcinoma (HCC) in vitro. SHILAP Revista de lepidopterología. 1 indexed citations
19.
Xia, Dajing, et al.. (2019). External ventricular drainage combined with continuous lumbar drainage in the treatment of ventricular hemorrhage. SHILAP Revista de lepidopterología. 1 indexed citations
20.
Dai, Yong. (2012). Clinical significance of the expression of hMLH1 and hMSH2 in colorectal cancer. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026